VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 75 filers reported holding VERSARTIS INC in Q4 2016. The put-call ratio across all filers is 2.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $135,000 | -70.4% | 82,073 | -60.4% | 0.00% | – |
| Q4 2017 | $456,000 | -35.7% | 207,051 | -28.5% | 0.00% | – |
| Q3 2017 | $709,000 | -85.9% | 289,526 | +0.2% | 0.00% | -100.0% |
| Q2 2017 | $5,042,000 | +33.3% | 288,960 | +63.1% | 0.00% | +33.3% |
| Q1 2017 | $3,782,000 | +94.6% | 177,136 | +35.9% | 0.00% | +200.0% |
| Q4 2016 | $1,943,000 | +83.0% | 130,377 | +50.4% | 0.00% | 0.0% |
| Q3 2016 | $1,062,000 | +8.0% | 86,707 | -2.4% | 0.00% | 0.0% |
| Q2 2016 | $983,000 | +65.8% | 88,837 | +20.1% | 0.00% | – |
| Q1 2016 | $593,000 | -35.3% | 73,980 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $917,000 | -10.2% | 73,980 | -16.5% | 0.00% | 0.0% |
| Q3 2015 | $1,021,000 | -1.1% | 88,546 | +30.5% | 0.00% | 0.0% |
| Q2 2015 | $1,032,000 | +108.1% | 67,828 | +151.1% | 0.00% | – |
| Q1 2015 | $496,000 | -9.7% | 27,010 | +10.5% | 0.00% | – |
| Q4 2014 | $549,000 | +9.8% | 24,454 | -7.0% | 0.00% | – |
| Q3 2014 | $500,000 | -32.2% | 26,308 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $738,000 | – | 26,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |